PATEL SANJIV (President and CEO) sold 7.4% of their position (61.38K shares) of RELAY THERAPEUTICS, INC. on the open market
Open‑market sale worth $219.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/10/2025ACC: 0000950170-25-095093
DirectorOfficer· President and CEO
Since Jul 2020
-61.38K
Net shares
Net seller
$219.1K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
61.38K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−42.74K
Price / share
$3.57
Trade value
$152.58K
% of position
5.2%
7/9/2025
826.67K→783.93K
Common Stock
Direct
Shares
−18.64K
Price / share
$3.57
Trade value
$66.54K
% of position
2.4%
7/9/2025
783.93K→765.29K
Total
Net shares
−61.38K
Net value
-$219.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/9/2025 | S · Sale | −42.74K | $3.57 | $152.58K | 5.2% | 826.67K | 783.93K |
| Common Stock Direct | 7/9/2025 | S · Sale | −18.64K | $3.57 | $66.54K | 2.4% | 783.93K | 765.29K |
| Total | −61.38K | -$219.12K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned199.55K
Common Stock
IndirectShares owned687.36K
Total
886.90K indirect886.90K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 199.55K | Indirect |
| Common Stock | 687.36K | Indirect |
| Total | 886.90K | 886.90K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported